MedPath

Comparison of three different drug regimens for sedation in children undergoing MRI

Recruiting
Conditions
Imaging, (2) ICD-10 Condition: 4||Measurement and Monitoring,
Registration Number
CTRI/2020/01/022949
Lead Sponsor
Dr Rohit
Brief Summary

Magnetic resonance imaging (MRI) is a widely used radiology technique with its unique noisy environment and a narrow pipe like appearance. However, it is very difficult for a child to remain motionless to avoid movement artefact, and get a qualified image. General anaesthesia or sedation is frequently required to eliminate motion artefacts and to attenuate anxiety during MRI in young children or in children with complex medical conditions. Propofol(PRO) and dexmedetomidine(DEX) are commonly used for maintaining anaesthesia and sedation, and both are safe and effective in children undergoing MRI with few component scan (e.g., brain) and of short duration (<1 h). Compared with pentobarbital, midazolam, and fentanyl techniques, propofol yields faster induction, shorter emergence, less duration in postanaesthesia care unit (PACU), and fewer interruptions during the MRI related to patient movement. However, arterial desaturation, hypotension and dose-dependent response of upper airway collapse (by inhibition of airway dilator muscle and of upper airway reflexes) occasionally occur with the propofol technique. In order to minimize these side effects, some authors recommend the combination with other drugs like midazolam, opioids, ketamine or dexmedetomidine. The increasing popularity of dexmedetomidine use in children stems from its ability to provide adequate procedural sedation with a relatively low risk of respiratory depression. In addition, dexmedetomidine is associated with a significantly lower need for artificial airway support during sedation for magnetic resonance imaging (MRI) in children with obstructive sleep apnea, compared to propofol.

Concomitant addition of two drugs can bring drug synergy effect on sedation and contributes to decreased risk of adverse effects. Therefore, by using combination regimen, it could provide short induction time, fast recovery, stable cardiorespiratory conditions, and rarely requires additional sedation, and therefore is safe and adequate for pediatric MRI sedation.

The goal of our study is to compare propofol (with and without ketamine) and dexmedetomidine based sedation regimens for pediatric MRI sedation with respect to several measures such as timeliness, safety profile, image and sedation quality outcomes, and parental satisfaction in children undergoing multicomponent MRI scan.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
51
Inclusion Criteria

American Society of Anaesthesiologists (ASA) status 1 and 2, Aged 1 to 10 years, Scheduled for elective MRI.

Exclusion Criteria

Significant cardiovascular or pulmonary pathology, Patients with any allergy or contraindication to study drugs, Anatomical anomaly or suspected difficulty of the airway.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to discharge from recovery room.at baseline, after completion of imaging procedure.
Secondary Outcome Measures
NameTimeMethod
Quality of Induction, Quality of sedation, quality of MRI
Scan duration.
Incidence of emergence delirium based on the pediatric anesthesia emergence delirium (PAED) scaleduring recovery from sedation
Parental satisfaction score about Anaesthesia and recovery.
Incidence of adverse events namely postoperative nausea and vomiting (PONV), hemodynamics, respiratory events.
Time to Induction of sleep
Recovery/Awakening timeTime to recovery from sedation to RSS 2 after stopping the drug infusion

Trial Locations

Locations (1)

Lok nayak hospital

🇮🇳

Central, DELHI, India

Lok nayak hospital
🇮🇳Central, DELHI, India
Dr Rohit
Principal investigator
09873520215
dr.rohitbalyan@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.